Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors-Reference-Cited by-同舟云学术

Cyclooxygenase-independent inhibitory effects on T cell activation of novel 4,5-dihydro-3 trifluoromethyl pyrazole cyclooxygenase-2 inhibitors

Published:2010-10 Issue:10 Volume:10 Page:1295-1304
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Iñiguez Miguel A.,Punzón Carmen,Cacheiro-Llaguno Cristina,Díaz-Muñoz Manuel D.,Duque Javier,Cuberes Rosa,Alvarez Inés,Andrés Eva M.,Buxens Jordi,Buschmann Helmut,Vela José M.,Fresno Manuel

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference64 articles.

1. Cyclooxygenase isoenzymes: the biology of prostaglandin synthesis and inhibition;Simmons;Pharmacol Rev,2004

2. Cyclooxygenase isozymes and their gene structures and expression;Tanabe;Prostaglandins Other Lipid Mediat,2002

3. Distinct functions of COX-1 and COX-2;Morita;Prostaglandins Other Lipid Mediat,2002

4. Cyclooxygenases: structural, cellular, and molecular biology;Smith;Annu Rev Biochem,2000

5. Cyclooxygenase inhibitors—current status and future prospects;Dannhardt;Eur J Med Chem,2001

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis of pyrazole and pyrazoline derivatives of β-ionone: Exploring anti-inflammatory potential, cytotoxicity, and molecular docking insights;European Journal of Medicinal Chemistry Reports;2024-12

2. Strategies and Methods for the Synthesis of 2‐Pyrazolines: Recent Developments (2012–2022);Advanced Synthesis & Catalysis;2023-06-02

3. Heterocycles in managing inflammatory diseases;Recent Developments in Anti-Inflammatory Therapy;2023

4. Synthesis, Anticancer and Antitubercular Properties of New Chalcones and Their Nitrogen-Containing Five-Membered Heterocyclic Hybrids Bearing Sulfonamide Moiety;International Journal of Molecular Sciences;2022-10-20

5. Pyrazoline Containing Compounds as Therapeutic Targets for Neurodegenerative Disorders;ACS Omega;2022-10-17